//

Media

Filter by Category

All Blog Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

Critical Path for Parkinson’s Welcomes New Co-chairs Pagano, Gaetano

Critical Path for Parkinson’s mission is to serve as a leading international consortium convening diverse stakeholders to

October 16, 2023

Transforming Drug Development for Neurological Disorders: Proceedings from a Multidisease Area Workshop

Neurological disorders represent some of the most challenging therapeutic areas for successful drug approvals.

October 11, 2023

Applying propensity methods to the United States transplant registry for external real-world evidence control arms for 5-year survival in the BENEFIT study

To address the challenges of assessing the impact of a reasonably likely surrogate endpoint on long-term graft survival....

October 3, 2023

C-Path Rare and Orphan Disease Conference Highlights Unprecedented Collaborations and Breakthroughs in Rare Disease Research

TUCSON, Ariz., October 3, 2023 — The Critical Path Institute (C-Path) held its highly anticipated Rare and Orphan Disease Confer

October 6, 2023

Innovative Trial Design Approaches to Model Informed Drug Development in Rare and Neurological Diseases

Are you passionate about making a difference in the fields of neurology and rare diseases? Do you want to explore new methods that

October 2, 2023-October 6, 2023

View Now — European Association of the Study of Diabetes Annual Meeting, C-Path T1D Consortium Presentation and Reception

Members of the C-Path team joined EASD 2023 for groundbreaking discussions on Immunotherapy and Beta Cell Preservation in Type 1 D

September 25, 2023

Qualifying a novel clinical trial endpoint (iBOX) predictive of long-term kidney transplant outcomes

New immunosuppressive therapies that improve long-term graft survival are needed in kidney transplant.

September 25, 2023

Qualifying a novel clinical trial endpoint (iBOX) predictive of long-term kidney transplant outcomes

New immunosuppressive therapies that improve long-term graft survival are needed in kidney transplant.

The CPP Consortium Welcomes Biohaven as its Newest Member

The Critical Path for Parkinson’s Consortium is excited to welcome Biohaven as its newest member. Biohaven is a biopha

September 18, 2023

C-Path and EATRIS Join Forces with New Collaboration Agreement

AMSTERDAM and TUCSON, Ariz., September 18, 2023 — Critical Path Institute (C-Path) and EATRIS (the European Research Infrastruct

Previous1415 16...114 Next